|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Parasitic diseases rank among the most prevalent infectious diseases. Chemotherapy forms the mainstay for control of parasites. Availability of antiparasitic drugs is limited due to high cost of development of newer drugs and rapid pace of development of resistance. Literature shows that resistance against all newly launched antiparasitic drugs is noticed within a decade time. Condition is severe and discouraging in tropical countries like India where animals carry substantial parasitic load and there is indiscriminate use of drugs. Anthelmintic resistance in helminthic parasites, particularly Haemonchus contortus are well reported from India. Molecular markers are identified for large scale screening of benzimidazole resistance. Chemotherapy being central to the control of parasites, drug resistance is likely to be a major issue in near future. Constant surveillance and monitoring of antiparasitic drug resistance is the need of the hour. The problem of resistance can be circumvented either by delaying its onset or use of alternate strategies in the form of integrated parasite management.